|
Journal of Bone and Joint Surgery - British Volume, Vol 86-B, Issue 1,
31-33.
doi: 10.1302/0301-620X.86B1.13936 Copyright © 2004 by British Editorial Society of Bone and Joint Surgery Treatment of anaemia after joint replacementA DOUBLE-BLIND, RANDOMISED, CONTROLLED TRIAL OF FERROUS SULPHATE VERSUS PLACEBOP. M. Sutton, FRCS (Trauma & Orth), Consultant Orthopaedic Surgeon; and T. Cresswell, FRCS (Ed), Specialist RegistrarDepartment of Trauma and Orthopaedics, Northern General Hospital, Herries Road, Sheffield S5 7AU, UK. J. P. Livesey, FRCS (Trauma & Orth), Consultant Orthopaedic Surgeon; K. Speed, MRC Path, Consultant Haematologist; and T. Bagga, FRCS (Orth), Consultant Orthopaedic Surgeon Diana, Princess of Wales Hospital, Scartho Road, Grimsby, North Lincolnshire DN33 2BA, UK. Correspondence should be sent to Mr P. M. Sutton. After total hip and knee replacement arthoplasty, patients may become anaemic and may be prescribed oral iron. There is, however, no published evidence that this is of benefit when used postoperatively. We treated 72 patients who were anaemic after primary total hip and knee arthroplasty by randomly allocating them to receive six weeks of either oral ferrous sulphate (35 patients) or a placebo (37 patients). Both groups of patients were similar in all aspects except for the treatment given. There was no statistically significant difference in the change of haemoglobin levels between the two groups. We therefore believe that the prescription of iron to all anaemic patients postoperatively should be avoided. The level of serum ferritin should be monitored at preoperative assessment. This article has been cited by other articles:
|
|
||||||||||||



